Form 4: Phio Pharmaceuticals Director Buys Shares
Insider Transaction (Form 4)
Ronald Todd Plott, a Director of Phio Pharmaceuticals Corp., purchased 10,000 shares of common stock on September 28, 2026.
Summary
- Open-market purchase: acquired 5,000 Common Stock, $.0001 par value at $1.03 ($5,150) on September 28, 2026; holds 37,000 after (Direct).
- Open-market purchase: acquired 5,000 Common Stock, $.0001 par value at $1.04 ($5,200) on September 29, 2026; holds 42,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $10,350, committing personal capital to the stock.
Insider Transactions
Ronald Todd Plott — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Open-market purchase | Common Stock, $.0001 par value | 5,000 | $1 | $5.2K | 37,000 |
| 2026-09-29 | Open-market purchase | Common Stock, $.0001 par value | 5,000 | $1 | $5.2K | 42,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Open-market purchase (5,000 shares) |
| 2026-09-29 | Open-market purchase (5,000 shares) |
Keywords
insider transaction, Form 4, PHIO, Phio Pharmaceuticals Corp., bullish, Ronald Todd Plott
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.